← Back to patent-cliff list
CAS 1398507-09-9
4-((4-amino-5-bromo-6-chloropyrimidin-2-yl)amino)benzonitrile
Codes: ETRA-024
Application context (from source-drug indications)
HIV infectionEtravirineFriedreich's ataxiaEtravirineInflammatory diseaseEtravirineInsulin resistanceEtravirine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Etravirine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-aminobenzonitrile→4-hydroxy-3,5-dimethylbenzonitrile→4-((4-amino-6-chloropyrimidin-2-yl)amino)benzonitrile→2,6-dichloropyrimidin-4-amine→4-((4-amino-5-bromo-6-chloropyrimidin-2-yl)amino)benzonitrile
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.